Clinical Trials Directory

Trials / Completed

CompletedNCT05260723

RISE - Reduce Sitting Time Among Breast Cancer Survivors

RISE - A Pilot Study to Reduce Sitting Time Among Breast Cancer Survivors

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
21 (actual)
Sponsor
University of California, San Diego · Academic / Other
Sex
Female
Age
50 Years
Healthy volunteers
Not accepted

Summary

This 3-month study will test whether a program to reduce sitting time, for breast cancer survivors experiencing some physical limitations, can improve their physical function and other important aspects of quality of life.

Detailed description

Many cancer survivors experience long-term physical problems following their cancer treatments and can often seem much older than same age peers who were never treated for cancer. This is known as accelerated aging. One way to improve accelerated aging is to increase moderate to vigorous intensity exercise; however, for many cancer survivors, especially those with physical limitations, increasing exercise levels is not possible. Another potential way to improve accelerated aging may be to decrease the amount of time spent sitting. Long periods of sitting are related to many physical and health problems. Cancer survivors spend more than 9 hours a day sitting and often increase the amount they sit after their cancer treatments. This study could help identify realistic intervention targets for many cancer survivors and be used to guide recommendations for improving physical function and quality of life after cancer.

Conditions

Interventions

TypeNameDescription
BEHAVIORALBehavioral: Sit LessThe Sit Less arm uses habit formation, social cognitive theory, and motivational interviewing techniques to support behavior change and includes: 1) 7 health coaching sessions to set personalized goals and review progress; 2) wearing an activPAL (thigh worn accelerometer that measures sitting time); 3) intervention tools to support behavior change (e.g., standing desk, wrist worn monitor).

Timeline

Start date
2022-03-29
Primary completion
2023-04-07
Completion
2023-05-07
First posted
2022-03-02
Last updated
2023-05-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05260723. Inclusion in this directory is not an endorsement.